Global In Vitro Fertilization Market 2022-2032

1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Fact.MR Analysis and Recommendations

2.1. Market Coverage
2.2. Market Definition

3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on In Vitro Fertilization /IVF
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends

4.1. In Vitro Fertilization /IVF Market, by Key Countries
4.2. In Vitro Fertilization /IVF Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. In Vitro Fertilization /IVF Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. In Vitro Fertilization /IVF Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking

6.1. Historical Market Analysis, 2015-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis

7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis

8.1. Introduction/Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Product , 2015-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product , 2022-2032
8.3.1. Equipment
8.3.1.1. Sperm Analyzer Systems
8.3.1.2. Imaging Systems
8.3.1.3. Ovum Aspiration Pumps
8.3.1.4. Micromanipulator Systems
8.3.1.5. Incubators
8.3.1.6. Gas Analyzers
8.3.1.7. Laser Systems
8.3.1.8. Cryosystems
8.3.1.9. Sperm Separation Devices
8.3.1.10. IVF Cabinets
8.3.1.11. Anti-vibration Tables
8.3.1.12. Witness Systems
8.3.1.13. Other Equipments
8.3.2. Reagents & Media
8.3.2.1. Cryopreservation Media
8.3.2.2. Embryo Culture Media
8.3.2.3. Ovum Processing Media
8.3.2.4. Sperm Processing Media
8.3.3. Accessories
8.4. Market Attractiveness Analysis By Product

9.1. Introduction/Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Cycle , 2015-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Cycle , 2022-2032
9.3.1. Fresh Non-donor IVF Cycles
9.3.2. Frozen Non-donor IVF Cycles
9.3.3. Frozen Donor IVF Cycles
9.3.4. Fresh Donor IVF Cycle
9.4. Market Attractiveness Analysis By Cycle

10.1. Introduction/Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By End User , 2015-2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User , 2022-2032
10.3.1. Fertility Clinics
10.3.2. Hospitals & Surgical Centers
10.3.3. Cryobanks
10.3.4. Research Institutes
10.4. Market Attractiveness Analysis By End User

11.1. Introduction/Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Type, 2015-2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2022-2032
11.3.1. Conventional IVF
11.3.2. IVF with ICSI
11.3.3. IVF with Donar Eggs
11.3.4. Others
11.4. Market Attractiveness Analysis By Type

12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021
12.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. Asia Pacific
12.3.5. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region

13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
13.4.1. By Country
13.4.1.1. U.S.
13.4.1.2. Canada
13.4.1.3. Rest of North America
13.4.2. By Product
13.4.3. By Cycle
13.4.4. By Type
13.4.5. By End User
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product
13.5.3. By Cycle
13.5.4. By Type
13.5.5. By End User

14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. Brazil
14.4.1.2. Mexico
14.4.1.3. Rest of Latin America
14.4.2. By Product
14.4.3. By Cycle
14.4.4. By Type
14.4.5. By End User
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product
14.5.3. By Cycle
14.5.4. By Type
14.5.5. By End User

15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. Germany
15.4.1.2. France
15.4.1.3. U.K.
15.4.1.4. Italy
15.4.1.5. Benelux
15.4.1.6. Nordic Countries
15.4.1.7. Rest of Europe
15.4.2. By Product
15.4.3. By Cycle
15.4.4. By Type
15.4.5. By End User
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product
15.5.3. By Cycle
15.5.4. By Type
15.5.5. By End User

16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
16.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
16.4.1. By Country
16.4.1.1. China
16.4.1.2. Japan
16.4.1.3. South Korea
16.4.1.4. Rest of Asia Pacific
16.4.2. By Product
16.4.3. By Cycle
16.4.4. By Type
16.4.5. By End User
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product
16.5.3. By Cycle
16.5.4. By Type
16.5.5. By End User

17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
17.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
17.4.1. By Country
17.4.1.1. GCC Countries
17.4.1.2. South Africa
17.4.1.3. Turkey
17.4.1.4. Rest of Middle East and Africa
17.4.2. By Product
17.4.3. By Cycle
17.4.4. By Type
17.4.5. By End User
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Product
17.5.3. By Cycle
17.5.4. By Type
17.5.5. By End User

18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. US In Vitro Fertilization /IVF Market Analysis
18.2.1. Value Proportion Analysis by Market Taxonomy
18.2.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.2.2.1. By Product
18.2.2.2. By Cycle
18.2.2.3. By Type
18.2.2.4. By End User
18.3. Canada In Vitro Fertilization /IVF Market Analysis
18.3.1. Value Proportion Analysis by Market Taxonomy
18.3.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.3.2.1. By Product
18.3.2.2. By Cycle
18.3.2.3. By Type
18.3.2.4. By End User
18.4. Mexico In Vitro Fertilization /IVF Market Analysis
18.4.1. Value Proportion Analysis by Market Taxonomy
18.4.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.4.2.1. By Product
18.4.2.2. By Cycle
18.4.2.3. By Type
18.4.2.4. By End User
18.5. Brazil In Vitro Fertilization /IVF Market Analysis
18.5.1. Value Proportion Analysis by Market Taxonomy
18.5.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.5.2.1. By Product
18.5.2.2. By Cycle
18.5.2.3. By Type
18.5.2.4. By End User
18.6. Germany In Vitro Fertilization /IVF Market Analysis
18.6.1. Value Proportion Analysis by Market Taxonomy
18.6.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.6.2.1. By Product
18.6.2.2. By Cycle
18.6.2.3. By Type
18.6.2.4. By End User
18.7. France In Vitro Fertilization /IVF Market Analysis
18.7.1. Value Proportion Analysis by Market Taxonomy
18.7.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.7.2.1. By Product
18.7.2.2. By Cycle
18.7.2.3. By Type
18.7.2.4. By End User
18.8. Italy In Vitro Fertilization /IVF Market Analysis
18.8.1. Value Proportion Analysis by Market Taxonomy
18.8.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.8.2.1. By Product
18.8.2.2. By Cycle
18.8.2.3. By Type
18.8.2.4. By End User
18.9. BENELUX In Vitro Fertilization /IVF Market Analysis
18.9.1. Value Proportion Analysis by Market Taxonomy
18.9.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.9.2.1. By Product
18.9.2.2. By Cycle
18.9.2.3. By Type
18.9.2.4. By End User
18.10. UK In Vitro Fertilization /IVF Market Analysis
18.10.1. Value Proportion Analysis by Market Taxonomy
18.10.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.10.2.1. By Product
18.10.2.2. By Cycle
18.10.2.3. By Type
18.10.2.4. By End User
18.11. Nordic Countries In Vitro Fertilization /IVF Market Analysis
18.11.1. Value Proportion Analysis by Market Taxonomy
18.11.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.11.2.1. By Product
18.11.2.2. By Cycle
18.11.2.3. By Type
18.11.2.4. By End User
18.12. China In Vitro Fertilization /IVF Market Analysis
18.12.1. Value Proportion Analysis by Market Taxonomy
18.12.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.12.2.1. By Product
18.12.2.2. By Cycle
18.12.2.3. By Type
18.12.2.4. By End User
18.13. Japan In Vitro Fertilization /IVF Market Analysis
18.13.1. Value Proportion Analysis by Market Taxonomy
18.13.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.13.2.1. By Product
18.13.2.2. By Cycle
18.13.2.3. By Type
18.13.2.4. By End User
18.14. South Korea In Vitro Fertilization /IVF Market Analysis
18.14.1. Value Proportion Analysis by Market Taxonomy
18.14.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.14.2.1. By Product
18.14.2.2. By Cycle
18.14.2.3. By Type
18.14.2.4. By End User
18.15. GCC Countries In Vitro Fertilization /IVF Market Analysis
18.15.1. Value Proportion Analysis by Market Taxonomy
18.15.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.15.2.1. By Product
18.15.2.2. By Cycle
18.15.2.3. By Type
18.15.2.4. By End User
18.16. South Africa In Vitro Fertilization /IVF Market Analysis
18.16.1. Value Proportion Analysis by Market Taxonomy
18.16.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.16.2.1. By Product
18.16.2.2. By Cycle
18.16.2.3. By Type
18.16.2.4. By End User
18.17. Turkey In Vitro Fertilization /IVF Market Analysis
18.17.1. Value Proportion Analysis by Market Taxonomy
18.17.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.17.2.1. By Product
18.17.2.2. By Cycle
18.17.2.3. By Type
18.17.2.4. By End User
18.17.3. Competition Landscape and Player Concentration in the Country

19.1. Market Analysis by Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis of Top Players
19.4. Market Presence Analysis
19.4.1. By Regional footprint of Players
19.4.2. Product footprint by Players

20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. The Cooper Companies Inc
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Sales Footprint
20.3.1.4. Strategy Overview
20.3.2. Cook Group
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Sales Footprint
20.3.2.4. Strategy Overview
20.3.3. Vitrolife
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Sales Footprint
20.3.3.4. Strategy Overview
20.3.4. Thermo Fisher Scientific, Inc
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Sales Footprint
20.3.4.4. Strategy Overview
20.3.5. Esco Micro
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Sales Footprint
20.3.5.4. Strategy Overview
20.3.6. Genea Limited
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Sales Footprint
20.3.6.4. Strategy Overview
20.3.7. IVFtech ApS
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Sales Footprint
20.3.7.4. Strategy Overview
20.3.8. FUJIFILM Irvine Scientific
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Sales Footprint
20.3.8.4. Strategy Overview
20.3.9. The Baker Company
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Sales Footprint
20.3.9.4. Strategy Overview
20.3.10. Kitazato Corporation
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Sales Footprint
20.3.10.4. Strategy Overview